ACTRN12618000426280尚未招募未知
The Sydney Triage to Admission Risk Tool (START) study: using a data analytics tool to drive early senior decision making and improve patient outcomes in Emergency Departments
Agency for Clinical Innovation0 个研究点目标入组 6,000 人开始时间: 2018年3月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 6,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
撤回
不适用
Phase I and IIa Trial for Assessment of Safety, Immunogenicity (Phase Ia) and Efficacy (Phase IIa) Against Sporozoite Challenge of P. Falciparum Pre-Erythrocytic and Blood Stage (PfPEBS-LSP) Malaria Vaccine CandidatePlasmodium falciparum10037072MalariaNL-OMON37083Vac4All36
已完成
不适用
An open-label, Phase I study to assess safety, tolerability, radiation dosimetry, and imaging properties of 89Zr-labelled girentuximab (89Zr-girentuximab) for in vivo detection of clear cell renal carcinoma (CCRC) by positron emission tomography (PET) using different PET imaging methodologies.clear cell renal carcinomakidney cancer10038364NL-OMON44583TELIX International Pty. Ltd.10
招募中
不适用
SATURN I Trial - Safety and performance Assessment of Therapeutic Ultrasound for the treatment of mitral RegurgitatioI34.0Mitral (valve) insufficiencyDRKS00000316ReCor Medical, Inc.10
进行中（未招募）
1 期
A phase I/II trail to evaluate the safety, feasibility and efficacy of the addition of temsirolimus (Torisel™) to a regimen of bendamustine and rituximab for the treatment of patients with follicular lymphoma or mantle cell lymphoma in fist to third relapse - BERTEUCTR2009-013351-30-DEniversitätsmedizin der Johannes Gutenberg-Universität Mainz70
招募中
不适用
The Signal - Trial: evaluation of a screening tool for psychosocial problems in cancer geneticspsychische problemen bij erfelijkheidsonderzoek voor kankerPsychosocial problemsNL-OMON35886ederlands Kanker Instituut200